Several brokerages have updated their recommendations and price targets on shares of Bio-Rad Laboratories (NYSE: BIO) in the last few weeks:
- 2/28/2018 – Bio-Rad Laboratories had its price target lowered by analysts at Wells Fargo & Co from $290.00 to $280.00. They now have an “outperform” rating on the stock.
- 2/28/2018 – Bio-Rad Laboratories had its price target raised by analysts at Jefferies Group LLC to $325.00. They now have a “buy” rating on the stock.
- 2/28/2018 – Bio-Rad Laboratories had its price target raised by analysts at Citigroup Inc to $325.00. They now have a “buy” rating on the stock.
- 2/16/2018 – Bio-Rad Laboratories was downgraded by analysts at CL King from a “buy” rating to a “neutral” rating.
Bio-Rad Laboratories, Inc. (NYSE BIO) opened at $262.34 on Wednesday. Bio-Rad Laboratories, Inc. has a fifty-two week low of $193.65 and a fifty-two week high of $279.59. The company has a quick ratio of 2.75, a current ratio of 3.93 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $7,737.79, a PE ratio of 68.86, a PEG ratio of 2.22 and a beta of 0.89.
Bio-Rad Laboratories (NYSE:BIO) last posted its quarterly earnings data on Tuesday, February 27th. The medical research company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.22. Bio-Rad Laboratories had a return on equity of 3.63% and a net margin of 5.31%. The firm had revenue of $620.43 million during the quarter, compared to analysts’ expectations of $618.89 million. research analysts anticipate that Bio-Rad Laboratories, Inc. will post 5.86 earnings per share for the current fiscal year.
Bio-Rad Laboratories, Inc (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Receive News & Ratings for Bio-Rad Laboratories Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories Inc and related companies with MarketBeat.com's FREE daily email newsletter.